{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:19:18Z","timestamp":1788304758348,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,30]]},"DOI":"10.7759\/cureus.91276","type":"journal-article","created":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T08:59:17Z","timestamp":1756544357000},"source":"Crossref","is-referenced-by-count":1,"title":["Cancer-Associated Venous Thromboembolic Disease: Anatomoclinical Aspects and Risk Factors"],"prefix":"10.7759","author":[{"given":"Imen","family":"Ketata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aloulou S","family":"Samir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abir","family":"Bouassida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten","family":"Dhouib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Bahri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadil","family":"Chaari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdani","family":"Moez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahma","family":"Kallel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayfa","family":"Rajhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Importance of cancer-related venous thromboembolism: first article in the 'Preventing Thrombosis' series","volume":"31","author":"Sardo LA","year":"2021","unstructured":"Sardo LA, Bayadinova JA, Jenkins S, Penton L. Importance of cancer-related venous thromboembolism: first article in the 'Preventing Thrombosis' series. Can Oncol Nurs J. 2021, 31:504-7.","journal-title":"Can Oncol Nurs J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-025-06208-8","article-title":"First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis","volume":"151","author":"Burkhard-Meier A","year":"2025","unstructured":"Burkhard-Meier A, Rechenauer VV, Jurinovic V, et al.. First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. J Cancer Res Clin Oncol. 2025, 151:150. 10.1007\/s00432-025-06208-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.3807","article-title":"Systemic therapies in advanced epithelioid haemangioendothelioma: a retrospective international case series from the World Sarcoma Network and a review of literature","volume":"10","author":"Frezza AM","year":"2021","unstructured":"Frezza AM, Ravi V, Lo Vullo S, et al.. Systemic therapies in advanced epithelioid haemangioendothelioma: a retrospective international case series from the World Sarcoma Network and a review of literature. Cancer Med. 2021, 10:2645-59. 10.1002\/cam4.3807","journal-title":"Cancer Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0119-2018","article-title":"Cancer-associated thrombosis: the when, how and why","volume":"28","author":"Fernandes CJ","year":"2019","unstructured":"Fernandes CJ, Morinaga LT, Alves JL \u00a0Jr, Castro MA, Calderaro D, Jardim CV, Souza R. Cancer-associated thrombosis: the when, how and why. Eur Respir Rev. 2019, 28:10.1183\/16000617.0119-2018","journal-title":"Eur Respir Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020259","article-title":"Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment","volume":"12","author":"Canonico ME","year":"2022","unstructured":"Canonico ME, Santoro C, Avvedimento M, et al.. Venous thromboembolism and cancer: a comprehensive review from pathophysiology to novel treatment. Biomolecules. 2022, 12:10.3390\/biom12020259","journal-title":"Biomolecules"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14900","article-title":"Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: an individual participant data meta-analysis","volume":"18","author":"Takada T","year":"2020","unstructured":"Takada T, van Doorn S, Parpia S, et al.. Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: an individual participant data meta-analysis. J Thromb Haemost. 2020, 18:2245-52. 10.1111\/jth.14900","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.09.007","article-title":"Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer","volume":"78","author":"Connolly GC","year":"2012","unstructured":"Connolly GC, Dalal M, Lin J, Khorana AA. Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. Lung Cancer. 2012, 78:253-8. 10.1016\/j.lungcan.2012.09.007","journal-title":"Lung Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdmv.2018.05.003","article-title":"Venous thromboembolism and pancreatic cancer (Article in French)","volume":"43","author":"Fr\u00e8re C","year":"2018","unstructured":"Fr\u00e8re C, Bournet B, Benzidia I, et al.. Venous thromboembolism and pancreatic cancer (Article in French). J Med Vasc. 2018, 43:246-54. 10.1016\/j.jdmv.2018.05.003","journal-title":"J Med Vasc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02448-w","article-title":"Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid","volume":"53","author":"Paredes-Ruiz D","year":"2022","unstructured":"Paredes-Ruiz D, G\u00f3mez-Cuervo C, G\u00f3mez-Mart\u00edn C, et al.. Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid. J Thromb Thrombolysis. 2022, 53:471-8. 10.1007\/s11239-021-02448-w","journal-title":"J Thromb Thrombolysis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001275","article-title":"Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Horsted F","year":"2012","unstructured":"Horsted F, West J, Grainge MJ. Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med. 2012, 9:e1001275. 10.1371\/journal.pmed.1001275","journal-title":"PLoS Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12910","article-title":"Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer","volume":"13","author":"Ades S","year":"2015","unstructured":"Ades S, Kumar S, Alam M, et al.. Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer. J Thromb Haemost. 2015, 13:998-1003. 10.1111\/jth.12910","journal-title":"J Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01795.x","article-title":"Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer","volume":"102","author":"Ma YY","year":"2011","unstructured":"Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye ZY, Tao HQ. Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer Sci. 2011, 102:336-42. 10.1111\/j.1349-7006.2010.01795.x","journal-title":"Cancer Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.073338","article-title":"Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study","volume":"98","author":"Dickmann B","year":"2013","unstructured":"Dickmann B, Ahlbrecht J, Ay C, et al.. Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica. 2013, 98:1309-14. 10.3324\/haematol.2012.073338","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay C","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017, 117:219-30. 10.1160\/TH16-08-0615","journal-title":"Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-020-01437-6","article-title":"The association between pulmonary embolism and the cancer-related genomic alterations in patients with NSCLC","volume":"21","author":"Xiong W","year":"2020","unstructured":"Xiong W, Du H, Ding W, Sun J, Xu M, Guo X. The association between pulmonary embolism and the cancer-related genomic alterations in patients with NSCLC. Respir Res. 2020, 21:185. 10.1186\/s12931-020-01437-6","journal-title":"Respir Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12426","article-title":"Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study","volume":"38","author":"Palareti G","year":"2016","unstructured":"Palareti G, Legnani C, Cosmi B, et al.. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: analysis of results obtained in the DULCIS study. Int J Lab Hematol. 2016, 38:42-9. 10.1111\/ijlh.12426","journal-title":"Int J Lab Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.2150","article-title":"Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival","volume":"24","author":"Alcalay A","year":"2006","unstructured":"Alcalay A, Wun T, Khatri V, Chew HK, Harvey D, Zhou H, White RH. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival. J Clin Oncol. 2006, 24:1112-8. 10.1200\/JCO.2005.04.2150","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.1810","article-title":"Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study","volume":"30","author":"Ahlbrecht J","year":"2012","unstructured":"Ahlbrecht J, Dickmann B, Ay C, et al.. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol. 2012, 30:3870-5. 10.1200\/JCO.2011.40.1810","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.906427","article-title":"Association between ABO blood group and venous thromboembolism risk in patients with peripherally inserted central catheters: a meta-analysis and systematic review","volume":"12","author":"Zhang Q","year":"2022","unstructured":"Zhang Q, Peng H, Hu L, Ren R, Peng X, Song J. Association between ABO blood group and venous thromboembolism risk in patients with peripherally inserted central catheters: a meta-analysis and systematic review. Front Oncol. 2022, 12:906427. 10.3389\/fonc.2022.906427","journal-title":"Front Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X14568705","article-title":"Approach to chemotherapy-associated thrombosis","volume":"20","author":"Oppelt P","year":"2015","unstructured":"Oppelt P, Betbadal A, Nayak L. Approach to chemotherapy-associated thrombosis. Vasc Med. 2015, 20:153-61. 10.1177\/1358863X14568705","journal-title":"Vasc Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181f9f7c3","article-title":"Hormone therapy and recurrence of venous thromboembolism among postmenopausal women","volume":"18","author":"Oli\u00e9 V","year":"2011","unstructured":"Oli\u00e9 V, Plu-Bureau G, Conard J, Horellou MH, Canonico M, Scarabin PY. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women. Menopause. 2011, 18:488-93. 10.1097\/gme.0b013e3181f9f7c3","journal-title":"Menopause"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2011.01.010","article-title":"Update in thrombosis and cancer (Article in French)","volume":"32","author":"Geffray L","year":"2011","unstructured":"Geffray L. Update in thrombosis and cancer (Article in French). Rev Med Interne. 2011, 32:265-7. 10.1016\/j.revmed.2011.01.010","journal-title":"Rev Med Interne"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222149","article-title":"Does anticoagulation needed for distally located incidental pulmonary thromboembolism in patients with active cancer?","volume":"14","author":"Chang H","year":"2019","unstructured":"Chang H, Kim MS, Lee SY, et al.. Does anticoagulation needed for distally located incidental pulmonary thromboembolism in patients with active cancer?. PLoS One. 2019, 14:e0222149. 10.1371\/journal.pone.0222149","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp JF","year":"2013","unstructured":"Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC. Epidemiology of cancer-associated venous thrombosis. Blood. 2013, 122:1712-23. 10.1182\/blood-2013-04-460121","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/RUQ.0b013e3181b24f6f","article-title":"Venous thrombosis in an outpatient oncologic center: distribution, type, and comorbidities","volume":"25","author":"Souza FF","year":"2009","unstructured":"Souza FF, Otero HJ, Erturk M, Rybicki FJ, Ramaiya N, Van den Abbeele AD, Di Salvo DN. Venous thrombosis in an outpatient oncologic center: distribution, type, and comorbidities. Ultrasound Q. 2009, 25:145-50. 10.1097\/RUQ.0b013e3181b24f6f","journal-title":"Ultrasound Q"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.1864","article-title":"Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management","volume":"21","author":"Donnellan E","year":"2014","unstructured":"Donnellan E, Kevane B, Bird BR, Ainle FN. Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol. 2014, 21:134-43. 10.3747\/co.21.1864","journal-title":"Curr Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399071-cancer-associated-venous-thromboembolic-disease-anatomoclinical-aspects-and-risk-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T08:59:18Z","timestamp":1756544358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399071-cancer-associated-venous-thromboembolic-disease-anatomoclinical-aspects-and-risk-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.91276","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,30]]}}}